fluorodeoxyglucose f18 has been researched along with risperidone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benito, C; Desco, M; Gispert, JD; Luque, R; Molina, V; Palomo, T; Pascau, J; Reig, S; Sanz, J; Sarramea, F | 1 |
| Lane, CJ; Liddle, PF; Ngan, ET; Ruth, TJ; Yatham, LN | 1 |
| Baldini Rossi, N; Bloom, R; Buchsbaum, MS; Hollander, E; Newmark, R; Pallanti, S; Platholi, J; Sood, E | 1 |
| Bernardo, M; Fernández-Egea, E; Font, M; Gutierrez, F; Lomena, F; Parellada, E; Pareto, D; Pavia, J; Ros, D; Simo, M | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and risperidone
| Article | Year |
|---|---|
Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Fluorodeoxyglucose F18; Frontal Lobe; Health Status; Humans; Male; Radiopharmaceuticals; Risperidone; Schizophrenia; Severity of Illness Index; Tomography, Emission-Computed | 2004 |
Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patients.
Topics: Adult; Analysis of Variance; Brain; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Positron-Emission Tomography; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 2006 |
2 other study(ies) available for fluorodeoxyglucose f18 and risperidone
| Article | Year |
|---|---|
Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain; Caudate Nucleus; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Prefrontal Cortex; Putamen; Radiopharmaceuticals; Risperidone; Schizophrenia; Severity of Illness Index; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Brain Mapping; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Linguistics; Male; Positron-Emission Tomography; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2008 |